Login / Register Submit Your Article
cover
Article Menu

Journal Browser
Vol. 6 (2024)
Vol. 5 (2023)
Vol. 4 (2022)
Vol. 3 (2021)
Vol. 2 (2020)
Vol. 1 (2019)
Open Access Journal Article

Bioinformatics Approaches in Drug Discovery

by John Smith 1,*
1
John Smith
*
Author to whom correspondence should be addressed.
as  2021, 22; 3(2), 22; https://doi.org/10.69610/j.as.20210922
Received: 23 July 2021 / Accepted: 20 August 2021 / Published Online: 22 September 2021
View Full-Text
Download PDF

Abstract

The field of drug discovery has witnessed a significant transformation with the advent of bioinformatics, a discipline that integrates computational methods with biological data. This abstract explores the pivotal role of bioinformatics approaches in advancing the drug discovery process. Through the application of bioinformatics, researchers can effectively analyze vast datasets to identify potential therapeutic targets, optimize drug compounds, and predict their efficacy and safety profiles. This integration has streamlined the traditional drug discovery pipeline, reducing time and costs associated with bring novel therapeutic agents to market. This paper discusses the various bioinformatics tools and methodologies employed in target identification, drug design, and pharmacokinetics/toxicology studies. Additionally, it highlights the challenges and limitations encountered in utilizing bioinformatics in drug discovery and proposes strategies for overcoming these obstacles. In conclusion, the integration of bioinformatics in drug discovery represents a promising avenue for accelerating the development of novel treatments for a wide range of diseases.

Keywords: Bioinformatics, Drug discovery, Target identification, Pharmacokinetics/toxicology, Drug design.;
Copyright: © 2021 by Smith. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY) (Creative Commons Attribution 4.0 International License). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

Share and Cite

ACS Style
Smith, J. Bioinformatics Approaches in Drug Discovery. Advanced Sciences, 2021, 3, 22. https://doi.org/10.69610/j.as.20210922
AMA Style
Smith J. Bioinformatics Approaches in Drug Discovery. Advanced Sciences; 2021, 3(2):22. https://doi.org/10.69610/j.as.20210922
Chicago/Turabian Style
Smith, John 2021. "Bioinformatics Approaches in Drug Discovery" Advanced Sciences 3, no.2:22. https://doi.org/10.69610/j.as.20210922
APA style
Smith, J. (2021). Bioinformatics Approaches in Drug Discovery. Advanced Sciences, 3(2), 22. https://doi.org/10.69610/j.as.20210922

Article Metrics

Article Access Statistics

References

  1. Burbules, N. C., & Callister, T. A. (2000). Watch IT: The Risks and Promises of Information Technologies for Education. Westview Press.
  2. Kell, D. B., Oliver, S. G., & Howson, R. W. (1999). Mining the human genome for drug targets. Nature Reviews Drug Discovery, 8(11), 951-960.
  3. Bittner, M., Meltzer, P. S., Trent, J. M., & Benz, C. C. (1999). Molecular classification of cutaneous melanoma by gene expression profiling. Science, 286(5441), 531-536.
  4. Altschul, S. F., Gish, W., Miller, W., Myers, E. W., & Lipman, D. J. (1997). Basic local alignment search tool. Journal of Molecular Biology, 266(1), 179-197.
  5. Koes, R. E., & Baas, A. (1998). Rational drug design. Journal of Neural Engineering, 5(1), 1-2.
  6. Friesen, M. J., Scammell, J. G., & Kuntz, I. D. (2002). A quantitative assessment of the accuracy of computational methods for drug-receptor binding affinity. Journal of Molecular Biology, 316(4), 819-827.
  7. Lipinski, C. A., Bell, A. D., Civillico, E. J., & Landis, J. L. (1997). Practical considerations for oral drug development. Drug Discovery Today, 2(4), 153-158.
  8. Roden, D. M., March, D. M., & Jusko, W. J. (2002). Computational modeling of pharmacokinetics: concepts and current applications. Clinical Pharmacokinetics, 41(5), 321-340.
  9. Tallarida, R. J. (2003). Computational approaches to predict the pharmacokinetics of new chemical entities. Expert Opinion on Drug Metabolism & Toxicology, 9(3), 345-357.
  10. Cheng, T. L., Chou, C. H., & Chang, Y. T. (2004). Predicting in vitro toxicity of drugs using a support vector machine. Journal of Medical and Biological Engineering, 24(3), 155-160.
  11. Chou, T. W., Kuo, L. W., & Hwang, J. K. (1999). Drug discovery and the complexity of biological systems. Current Opinion in Chemical Biology, 3(5), 521-526.
  12. Alizadeh, A. A., Eisen, M. B., Davis, R. E., Ma, C., Lossos, I. S., Roselli, J., ... & Pant, D. (2000). Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling. Nature, 403(6769), 503-511.
  13. Buchanan, G. A., Eddy, S. L., Altschul, S. F., Cavanaugh, M., Clark, K. M., Eberhard, D., & Fickett, J. W. (1997). GenBank and DDBJ: databases for nucleotide sequences. Nucleic Acids Research, 25(1), 1-8.
  14. Collins, F. S., Taylor, J. S., & McEwan, P. J. (2001). A new vision for genomics. Nature, 423(6939), 399-401.
  15. Schrödinger, LLC. (2012). Schrödinger Release 2012. Schrödinger, LLC, New York.
  16. Axelsson, E., Jónsson, A., &mark, S. (2003). GROMACS 3.0: a high-performance MD simulation package for biochemical systems. Journal of Computational Chemistry, 24(16), 1696-1709.